Erel Joffe

2.4k total citations
63 papers, 503 citations indexed

About

Erel Joffe is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology. According to data from OpenAlex, Erel Joffe has authored 63 papers receiving a total of 503 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Pathology and Forensic Medicine, 22 papers in Genetics and 22 papers in Oncology. Recurrent topics in Erel Joffe's work include Lymphoma Diagnosis and Treatment (36 papers), Chronic Lymphocytic Leukemia Research (20 papers) and Viral-associated cancers and disorders (9 papers). Erel Joffe is often cited by papers focused on Lymphoma Diagnosis and Treatment (36 papers), Chronic Lymphocytic Leukemia Research (20 papers) and Viral-associated cancers and disorders (9 papers). Erel Joffe collaborates with scholars based in United States, Israel and Germany. Erel Joffe's co-authors include Elmer V. Bernstam, Craig Johnson, Dan Justo, Jorge R Herskovic, Michael Byrne, Brandon S. Imber, Irit Avivi, Anas Younes, Nadav Sarid and Todd R. Johnson and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Annals of Internal Medicine.

In The Last Decade

Erel Joffe

59 papers receiving 487 citations

Peers

Erel Joffe
Sara Ekberg Sweden
Talal Hilal United States
Sara Schoenfeld United States
Lucie Obéric France
Erica Linden United States
Laura Ferrari Italy
Mengyang Di United States
Sabarish Ayyappan United States
Ryan A. Metcalf United States
Ani John United States
Sara Ekberg Sweden
Erel Joffe
Citations per year, relative to Erel Joffe Erel Joffe (= 1×) peers Sara Ekberg

Countries citing papers authored by Erel Joffe

Since Specialization
Citations

This map shows the geographic impact of Erel Joffe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erel Joffe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erel Joffe more than expected).

Fields of papers citing papers by Erel Joffe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erel Joffe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erel Joffe. The network helps show where Erel Joffe may publish in the future.

Co-authorship network of co-authors of Erel Joffe

This figure shows the co-authorship network connecting the top 25 collaborators of Erel Joffe. A scholar is included among the top collaborators of Erel Joffe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erel Joffe. Erel Joffe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ghione, Paola, Erel Joffe, M. Lia Palomba, et al.. (2024). CD5 expression in marginal zone lymphoma does not predict inferior outcome and has similarities to indolent lymphomas. PubMed. 1(4). 100031–100031. 1 indexed citations
2.
Freret, Morgan E., Kathryn R. Tringale, Brandon S. Imber, et al.. (2023). Very low-dose radiotherapy for extranodal marginal zone lymphoma of bronchus-associated lymphoid tissue. Leukemia & lymphoma. 64(13). 2195–2201. 2 indexed citations
3.
Haverkos, Bradley M., Önder Alpdoğan, Robert A. Baiocchi, et al.. (2023). Targeted therapy with nanatinostat and valganciclovir in recurrent EBV-positive lymphoid malignancies: a phase 1b/2 study. Blood Advances. 7(20). 6339–6350. 25 indexed citations
4.
Kumar, Anita, Carla Casulo, Erel Joffe, et al.. (2022). Bendamustine in combination with ofatumumab as first line treatment for elderly patients with mantle cell lymphoma: a phase II risk-adapted design. Leukemia & lymphoma. 63(12). 2889–2896. 1 indexed citations
5.
Qi, Shu‐Nan, Xin Liu, Ariela Noy, et al.. (2022). Predictors of survival in patients with MALT lymphoma: a retrospective, case-control study. Blood Advances. 7(8). 1496–1506. 7 indexed citations
6.
Nowakowski, Grzegorz S., Dok Hyun Yoon, Anthea Peters, et al.. (2022). Improved Efficacy of Tafasitamab plus Lenalidomide versus Systemic Therapies for Relapsed/Refractory DLBCL: RE-MIND2, an Observational Retrospective Matched Cohort Study. Clinical Cancer Research. 28(18). 4003–4017. 16 indexed citations
7.
Lumish, Melissa, Lorenzo Falchi, Brandon S. Imber, et al.. (2021). How we treat mature B-cell neoplasms (indolent B-cell lymphomas). Journal of Hematology & Oncology. 14(1). 5–5. 22 indexed citations
8.
Joffe, Erel, Yan Leyfman, Esther Drill, et al.. (2021). Active surveillance of primary extranodal marginal zone lymphoma of bronchus-associated lymphoid tissue. Blood Advances. 5(2). 345–351. 7 indexed citations
9.
Joffe, Erel, Uri Greenbaum, Kalman Filanovsky, et al.. (2020). Kinetics of pre‐myelodysplastic syndromes blood values correlate with disease risk and survival. Hematological Oncology. 38(5). 782–791. 1 indexed citations
10.
Borchmann, Sven, Erel Joffe, Craig H. Moskowitz, et al.. (2019). Active surveillance for nodular lymphocyte-predominant Hodgkin lymphoma. Blood. 133(20). 2121–2129. 26 indexed citations
11.
Greenbaum, Uri, Erel Joffe, Kalman Filanovsky, et al.. (2018). Can bone marrow cellularity help in predicting prognosis in myelodysplastic syndromes?. European Journal Of Haematology. 101(4). 502–507. 8 indexed citations
12.
Joffe, Erel, Neta Goldschmidt, Osnat Bairey, et al.. (2018). Outcomes of second‐line treatment after fludarabine cyclophosphamide and rituximab in patients with chronic lymphocytic leukemia outside clinical trials. European Journal Of Haematology. 101(3). 399–406. 5 indexed citations
13.
Joffe, Erel, Dana Rosenberg, Uri Rozovski, et al.. (2017). Replacing carmustine by thiotepa and cyclophosphamide for autologous stem cell transplantation in Hodgkin’s and non-Hodgkin’s B-cell lymphoma. Bone Marrow Transplantation. 53(1). 29–33. 9 indexed citations
14.
Joffe, Erel, Osnat Bairey, Riva Fineman, et al.. (2017). Persistently low lymphocyte counts after FCR therapy for chronic lymphocytic leukemia are associated with longer overall survival. Hematological Oncology. 36(1). 128–135. 3 indexed citations
15.
Justo, Dan, et al.. (2017). Gender differences in mortality among statin users aged 80 years or more. Zeitschrift für Gerontologie und Geriatrie. 51(8). 882–888.
16.
Tovia‐Brodie, Oholi, Yael Ben‐Haim, Erel Joffe, et al.. (2016). The value of electrophysiologic study in decision-making regarding the need for pacemaker implantation after TAVI. Journal of Interventional Cardiac Electrophysiology. 48(2). 121–130. 34 indexed citations
17.
Amit, Odelia, et al.. (2016). Continuing dilemmas in the management of lymphoma during pregnancy: review of a 10-point case-based questionnaire. International Journal of Clinical Oncology. 22(1). 190–199. 12 indexed citations
18.
19.
Joffe, Erel, James P. Turley, Kevin O. Hwang, et al.. (2013). Errors in after-hours phone consultations: a simulation study. BMJ Quality & Safety. 23(5). 398–405. 2 indexed citations
20.
Joffe, Erel, Michael Byrne, Jorge R Herskovic, et al.. (2013). A benchmark comparison of deterministic and probabilistic methods for defining manual review datasets in duplicate records reconciliation. Journal of the American Medical Informatics Association. 21(1). 97–104. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sara Ekberg Breakdown of academic impact, for papers by Talal Hilal Breakdown of academic impact, for papers by Sara Schoenfeld Breakdown of academic impact, for papers by Lucie Obéric Breakdown of academic impact, for papers by Erica Linden Breakdown of academic impact, for papers by Laura Ferrari Breakdown of academic impact, for papers by Mengyang Di Breakdown of academic impact, for papers by Sabarish Ayyappan Breakdown of academic impact, for papers by Ryan A. Metcalf Breakdown of academic impact, for papers by Ani John
Rankless by CCL
2026